TICKERNERD
Menu
ACAACAIndustrials · Engineering & Construction

ACA Stock Forecast: Arcosa, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$145
+0.30% on the day

The 3 Wall Street analysts covering Arcosa, Inc. hold a median 12-month price target of $150 — +3.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 50 of 100 as at 15 Aug 2026 — in the upper half.

Market cap
$7.1B
Ticker Nerd rank
50 / 100
Median analyst target
$150
Analysts covering
3
Total return, dividends reinvested
1W
+0.4%
1M
+0.3%
YTD
+36.9%
1Y
+50.0%
From 52W high
0.0%
From 52W low
+63.4%
$89
$145
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ACA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Arcosa, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
50 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
97
Issuance
92
Accruals
56
Volatility
54
Revisions
50
Growth
46
Quality
35
Value
21
Size
20

Momentum (97): The shares have been drifting up relative to others.

Value (21): The shares cost a lot relative to the profits and assets behind them.

Size (20): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ACA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ACA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$90$100$110$120$130$140$150Oct 25Jan 26Apr 26Jul 26ACAHigh $150Median $150Low $140

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
1 Buy2 Hold0 Sell
Low $140Median $150High $150

The green dot is the last close — the median target sits +3.2% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
28 May 2026OppenheimerAssumesOutperform$150
4 May 2026BarclaysMaintainsOverweight—
2 Mar 2026DA DavidsonMaintainsBuy—
3 Nov 2025BarclaysMaintainsOverweight—
11 Aug 2025DA DavidsonMaintainsBuy—
14 Jan 2025OppenheimerMaintainsOutperform—
29 Oct 2024BarclaysInitiatesOverweight—
19 Aug 2024OppenheimerMaintainsOutperform—
7 Aug 2024Stephens & Co.UpgradeOverweight—
17 May 2024DA DavidsonMaintainsBuy—
6 May 2024DA DavidsonMaintainsBuy—
28 Feb 2024DA DavidsonMaintainsBuy—
23 Feb 2024OppenheimerMaintainsOutperform—
17 Oct 2023Sidoti & Co.UpgradeBuy—
8 Aug 2023Stephens & Co.MaintainsEqual-Weight—
7 Aug 2023DA DavidsonMaintainsBuy—
7 Aug 2023Loop CapitalMaintainsBuy—
8 May 2023OppenheimerMaintainsOutperform—
1 May 2023DA DavidsonMaintainsBuy—
1 May 2023Loop CapitalMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ACA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ACA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−1.1%
Analysts raising
2
Analysts cutting
1
Fundamentals

Arcosa, Inc. (ACA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
32.5×

Cheaper than 25% of US stocks

Price / sales
2.4×

Cheaper than 48% of US stocks

Price / book
2.7×

Cheaper than 38% of US stocks

EV / EBITDA
14.9×

Cheaper than 24% of US stocks

Growth & margins
Revenue growth (YoY)
1.7%

Higher than 32% of US stocks

Earnings growth (YoY)
450.3%

Higher than 95% of US stocks

Gross margin
23.6%

Higher than 26% of US stocks

Operating margin
12.3%

Higher than 68% of US stocks

Net margin
16.8%

Higher than 80% of US stocks

Returns & dividend
Return on equity
8.0%

Higher than 59% of US stocks

Return on assets
3.9%

Higher than 70% of US stocks

Dividend yield
0.1%

Higher than 2% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ACA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelEngineering & Construction
CompanyMarket capTKN rank
ACAArcosa, Inc.$7.1B
50
LGNLegence Corp.$7.2B
27
ECGEverus Construction Group, Inc.$7.2B
91
FLRFluor Corp.$7.0B
58
ROADConstruction Partners, Inc.$6.9B
73
AGXArgan, Inc.$8.1B
93
ACMAECOM$8.4B
37

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Arcosa, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ACA news & analysis

Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?

Zacks Investment Research · 7 Aug 2026neutral

Zacks reports that CRH's $8.5 billion deal for Arcosa could expand its exposure to U.S. aggregates and energy infrastructure, while noting financing and integration risks. The deal involves potential risks alongside the expansion opportunity.

Why it matters — ACA watchers would care because the report highlights the potential scope and risks of CRH's acquisition of Arcosa, affecting the company's future positioning in U.S. aggregates and energy infrastructure.

Arcosa (ACA) Q2 Earnings and Revenues Lag Estimates

Zacks Investment Research · 6 Aug 2026negative

Arcosa reported second-quarter earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.18 per share and falling from $1.27 per share in the same quarter a year ago. Revenues also lagged estimates.

Why it matters — A missed earnings estimate and year-over-year earnings decline signal weaker-than-expected quarterly performance for Arcosa, which ACA watchers would track closely.

Here's What Key Metrics Tell Us About Arcosa (ACA) Q2 Earnings

Zacks Investment Research · 6 Aug 2026neutral

A Zacks Investment Research report reviews Arcosa's (ACA) second-quarter 2026 results, noting that the top- and bottom-line figures indicate how the business performed. The article suggests examining key metrics to compare them against Wall Street estimates and year-ago values.

Why it matters — Arcosa watchers would care because the review highlights how the company's quarterly performance lines up with analyst expectations and prior-year results.

Arcosa, Inc. Announces Second Quarter 2026 Results

Business Wire · 5 Aug 2026neutral

Arcosa, Inc. announced results for the second quarter ended June 30, 2026, reporting continuing operations revenue of $658.7 million, up 2% from $647.5 million in the year-ago period. The figures exclude results from its barge business.

Why it matters — The report provides an updated view of Arcosa's core infrastructure business performance and revenue trajectory for the quarter.

FAQ

Frequently asked questions about ACA stock

What is the ACA stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Arcosa, Inc. have a median 12-month price target of $150, with estimates ranging from $140 to $150. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ACA stock a buy right now?

Of the 3 analysts covering Arcosa, Inc., 1 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Arcosa, Inc. 50 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ACA?

As at 15 Aug 2026, Arcosa, Inc. ranks 50 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (97 of 100).

Will ACA stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +3.2% from the last close, and Ticker Nerd's factor model ranks Arcosa, Inc. 50 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ACA stock forecast for 2030?

No analyst covering Arcosa, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ACA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $140 to $150 over the next 12 months.

How has ACA stock performed over the past year?

Arcosa, Inc. returned +50.0% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Arcosa, Inc. do?

Arcosa Inc. is an industrial company that provides infrastructure-related products and solutions across North America.

What is the latest news on ACA?

The most recent item we track (Zacks Investment Research, 7 Aug 2026): "Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?". Zacks reports that CRH's $8.5 billion deal for Arcosa could expand its exposure to U.S. aggregates and energy infrastructure, while noting financing and integration risks. The deal involves potential risks alongside the expansion opportunity.

Company

About Arcosa, Inc.

Arcosa Inc. is an industrial company that provides infrastructure-related products and solutions across North America. The business is organized into three primary segments: Construction Products, Engineered Structures, and Transportation Products. Within Construction Products, Arcosa produces and supplies construction aggregates, as well as trench shields and shoring equipment used in a wide range of infrastructure and construction projects. The Engineered Structures segment focuses on products for energy and utilities, including structural wind towers, steel utility structures for electricity transmission and distribution, telecommunications structures, and specialized storage and distribution containers. The Transportation Products segment manufactures equipment serving inland waterway and rail transportation markets. Collectively, Arcosa plays a significant role in supporting construction, energy, transportation, and utility industries by supplying essential physical components and systems. Founded in 2018 and headquartered in Dallas, Texas, Arcosa operates as a key infrastructure partner to public and private sector customers seeking durable, engineered solutions for critical assets and networks.

CEO Mr. Antonio Carrillo Rule · 6,390 employees · United States · https://www.arcosa.com